Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,758,573 Methods to protect against and treat multiple sclerosis
The invention provides epsilon toxin (ETX) produced by Clostridium perfringens type B or type D as a causative toxin for human multiple sclerosis (MS). The...
US-9,758,572 Anti-glucosaminidase passive immunization for Staphylococcus aureus infections
The present invention is directed to a monoclonal antibody that binds specifically to a Staphylococcus aureus glucosaminidase and inhibits in vivo growth of S....
US-9,758,571 Antibody for epitope tagging, hybridoma cell line and uses thereof
There are provided peptide tags derived from bacteriophytochrome (BphP) that is photoreceptor protein of Deinococcus radiodurans, an antibody capable of...
US-9,758,570 Preparation and composition of inter-alpha inhibitor proteins from blood
The present invention generally provides processes for purification of Inter-alpha inhibitor proteins (I.alpha.Ip) and compositions thereof from blood.
US-9,758,569 Collagen mimics
Novel collagen mimics are disclosed with a tripeptide unit having the formula (Xaa-Yaa-Gly).sub.n, where one of the positions Xaa or Yaa is a bulky,...
US-9,758,568 Oligopeptide-free cell culture media
The present invention relates to oligopeptide-free cell culture media comprising at least 0.5 mg/L of a polyamine and to methods for cultivating cells in said...
US-9,758,567 Hemojuvelin fusion proteins and uses thereof
The present invention provides a hemojuvelin (HJV) fusion protein (e.g., a human HJV.Fc) protein, polynucleotides and vectors encoding such proteins, and...
US-9,758,566 Recombinant cytotoxic T-lymphocyte-associated protein 4 (CTLA4)
This invention relates to recombinant CTLA-4 proteins, e.g., soluble CTLA-4 or CTLA-4 fusion toxins, and methods for making and using them.
US-9,758,565 Methods of treatment using CTLA4 mutant molecules
The present invention provides soluble CTLA4 mutant molecules which bind with greater avidity to the CD80 and/or CD86 antigen than wild type CTLA4 or...
US-9,758,564 Acid-resistant yeast cell with reduced FPS1 activity and method of producing lactate by using the yeast cell
Provided are an acid-resistant yeast cell with genetic modification and reduced Fps1 activity compared to that of a parent cell without the genetic...
US-9,758,563 Insulin analogues with chlorinated amino acids and nucleic acids encoding the same
An insulin analog comprises a B-chain polypeptide incorporating a chlorinated phenylalanine. The chlorinated phenylalanine may be located at position B24. The...
US-9,758,562 Glucagon/GLP-1 receptor co-agonists
Provided herein are peptides and variant peptides that exhibit enhanced activity at the GLP-1 receptor, as compared to native glucagon.
US-9,758,561 Dual GLP-1/glucagon receptor agonists derived from exendin-4
The present invention relates to dual GLP-1/glucagon receptor agonists and their medical use, for example in the treatment of disorders of the metabolic...
US-9,758,560 GLP-1 derivatives
The invention relates to a derivative of a GLP-1 peptide, which peptide has two Lys residues, namely a first and a second Lys residue, and a maximum of eight...
US-9,758,559 Short peptides derived from VDAC1, compositions and methods of use thereof
The present invention relates to short peptides based on the amino acids sequence of the N-terminal domain of the human mitochondrial protein voltage-dependent...
US-9,758,558 Whey protein isolate hydrogels and their uses
A biodegradable hydrogel has been made based on high concentrations of whey protein isolate (WPI). WPI gels of different compositions were fabricated by...
US-9,758,557 C1q peptides and uses thereof
Isolated C1q peptides, fusion proteins and compositions comprising such and fusion proteins comprising are provided. Isolated fusion proteins comprising...
US-9,758,556 Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5
The present invention relates to methods for treating and/or preventing tumors and/or promoting apoptosis in a neoplastic cell comprising contacting the...
US-9,758,555 Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5
The present invention relates to methods for treating and/or preventing tumors and/or promoting apoptosis in a neoplastic cell comprising contacting the...
US-9,758,554 Muteins of .alpha..sub.1m lipocalin and method of production therefor
The present disclosure relates to a collection of novel muteins derived from human .alpha.1m (or a1m) polypeptide or a functional homolog thereof. The...
US-9,758,553 Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose
Lower eukaryotic host cells have been engineered to produce glycoprotein having at least one terminal .alpha.-galactosyl epitope. The glycoproteins are useful...
US-9,758,552 HB-EGF inhibitor derived from the R domain of diphtheria toxin for the treatment of diseases associated with...
A ligand recombinant protein inhibiting HB-EGF (Heparin-Binding Epidermal Growth Factor like), from the R domain of diphtheria toxin, which can be used for the...
US-9,758,551 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
Nucleic acids encoding a chimeric or fusion polypeptide which polypeptide comprises a first domain comprising a translocation polypeptide; and a second domain...
US-9,758,550 Cobalamin acquisition protein and use thereof
The present invention relates to a cobalamin acquisition protein, compositions containing the cobalamin acquisition protein, and the use of such compositions.
US-9,758,549 Melanocortin receptor ligands modified with hydantoin
The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the...
US-9,758,548 Anti-microbial peptides and uses of same
A method of treating a bacterial infection in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of a...
US-9,758,547 Ligand functionalized polymers
Ligand functionalized substrates, methods of making ligand functionalized substrates, and methods of using functionalized substrates are disclosed.
US-9,758,546 Method for solution phase detritylation of oligomeric compounds
Provided herein are methods for the synthesis of oligomeric compounds wherein removal of the 5'-terminal trityl group is performed at reduced temperature and...
US-9,758,545 Sensor with a scaffold having changeable conformations
The present invention relates to a scaffolded sensor with a container comprising a drug for triggering drug release, wherein the scaffold is intrinsically...
US-9,758,544 Substituted nucleosides, nucleotides and analogs thereof
Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection...
US-9,758,543 Alkenyl glycosides and their preparation
An alkenyl glycoside is prepared by reacting a metathesis-derived unsaturated fatty alcohol containing 10 to 30 carbon atoms with either (1) a reducible...
US-9,758,542 Protein chromatography matrices with hydrophilic copolymer coatings
A coating of a random copolymer of acrylamide and a second monomer, e.g. glycidoxylmethacrylate, for a silica surface is described. The coating is applied to...
US-9,758,541 Metallocene derivatives with anticancer activity
The present invention relates to a compound of the following formula (I) or a pharmaceutically acceptable salt or solvate thereof, a stereoisomer or a mixture...
US-9,758,540 Bicyclic bridged metallocene compounds and polymers produced therefrom
Disclosed herein are catalyst compositions containing bicyclic bridged metallocene compounds. These catalyst compositions can be used for the polymerization of...
US-9,758,539 Alvocidib prodrugs having increased bioavailability
Compounds having the following structure (I): ##STR00001## or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein one of R.sup.1,...
US-9,758,538 Pyrimidine derivatives
The present invention relates to compounds of formula (I) ##STR00001## or pharmaceutically acceptable salts thereof, wherein X, Y, Z, R.sup.1-R.sup.11, m, n,...
US-9,758,537 Compounds for treatment of complement mediated disorders
Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition...
US-9,758,536 Phospholipid compositions enriched for palmitoleic, myristoleic or lauroleic acid, their preparation and their...
The present invention concerns phospholipid compositions having a relatively high concentration of compounds of the following structure (I): wherein at least...
US-9,758,535 Silicone surfactants for emulsion assays
System, including methods and compositions, for making and using emulsions that include a silicone oil and a silicone surfactant. The emulsions may include...
US-9,758,534 Organoaminosilanes and methods for making same
Organoaminosilanes, such as without limitation di-iso-propylaminosilane (DIPAS), are precursors for the deposition of silicon containing films such as...
US-9,758,533 Rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjunction...
A reaction method comprising combining a carbonyl-substituted arylboronic acid or ester and an .alpha.-effect amine in aqueous solution at a temperature between...
US-9,758,532 Compositions and methods comprising porous metal organic frameworks and related uses
Compositions and methods comprising metal organic frameworks (MOFs) and related uses are generally provided. In some embodiments, an MOF comprises a plurality...
US-9,758,531 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof
Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an azaindazole...
US-9,758,530 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
The invention provides novel compounds having the general formula: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined in the description...
US-9,758,529 Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disorders
Disclosed are compounds of Formula (I): ##STR00001## and pharmaceutically acceptable salts thereof, wherein Ring B, A.sup.1, A.sup.2, R.sup.6, w and n1 are...
US-9,758,528 Production method of thienopyrimidine derivative
The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH)...
US-9,758,527 Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating...
The present invention relates to: a cyclohexene derivative; a preparation method therefor; and a pharmaceutical composition for preventing or treating metabolic...
US-9,758,526 Quinoline-substituted compound
An object to be achieved by the present invention is to provide a novel compound having EGFR inhibitory effects and cell growth inhibitory effects, as well as a...
US-9,758,525 Spiro-lactam NMDA receptor modulators and uses thereof
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of...
US-9,758,524 4-imidazopyridazin-1-yl-benzamides as Btk inhibitors
The present invention relates to 6-5 membered fused pyridine ring compounds according to Formula (I) ##STR00001## or a pharmaceutically acceptable salt...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.